The effect of zinc sulfate on immunologic response to recombinant hepatitis B vaccine in elderly

Hepatitis Monthly

Volumn 11, Issue 1, 2011, Pages 32-35

  Afsharian, Mandana ^a   Vaziri, Siavash ^a   Janbakhsh, Ali Reza ^a   Sayad, Babak ^a   Mansouri, Feizollah ^a   Nourbakhsh, Javad ^a   Qadiri, Keyghobad ^b   Najafi, Farid ^a   Shirvanii, Maria ^a  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis B vaccination zinc sulfate immunity

Indexed keywords

HEPAVAX; PLACEBO; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG; ZINC SULFATE;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION PREVENTION; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 79956227126     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337(24):1733-45.
2. Alavian SM. Immunization: an important strategy to control hepatitis B. Hepat Mon. 2006;6(1):3-5.
3. Rink L, Gabriel P. Zinc and the immune system. Proc Nutr Soc. 2000;59(4):541-552.
4. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Lankarani KB. Hepatitis B Virus infection in Iran: A systematic review. Hepat Mon. 2008;8(4):281-294.
5. Khedmat H, Alavian SM, Miri SM, Amini M, Abolghasemi H, Hajibeigi B, et al. Trends in seroprevalence of hepatitis B, hepatitis C, HIV, and syphilis infections in Iranian blood donors from 2003 to 2005. Hepat Mon. 2009;9(1):24-8.
6. Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis. 2002;35(11):1368-75.
7. Hashemi SA, Moghadami M, Lankarani KB, Alborzi A, Mahbudi A. The Efficacy of Hepatitis B Vaccination among School Age Children in Southern Iran. IRCMJ. 2010;12(1):45-8.
8. Ada G. Vaccines and vaccination. N Engl J Med. 2001;345(14):1042-53.
9. Vaziri S, Janbakhsh A, Sori B. Evaluation of antibody production after hepatitis B vaccination by simple and rapid method. Kermanshah: Kermanshah University of Medical Sciences, Center IDR; 1385.
10. Saper RB, Rash R. Zinc: an essential micronutrient. Am Fam Physician. 2009;79(9):768-72.
11. Ibs KH, Rink L. Zinc-altered immune function. J Nutr. 2003;133(5 Suppl 1):1452S-456S.
12. Argani H, Akhtarishojaie E. Levamizole enhances immune responsiveness to intra-dermal and intra-muscular hepatitis B vaccination in chronic hemodialysis patients. J Immune Based Ther Vaccines. 2006;4:3.
13. Sharifi-Mood B, Izadi S, Salehi M, Qaedi H. Comparison of Immunogenicity of Low-Dose Intradermal Hepatitis B Vaccine with the Standard-Dose Intramuscular Vaccination in Young Healthy Iranian Adults. Hepat Mon. 2008;8(2):111-4.
14. Hodkinson CF, Kelly M, Alexander HD, Bradbury I, Robson PJ, Bonham MP, et al. Effect of zinc supplementation on the immune status of healthy older individuals aged 55-70 years: the ZENITH Study. J Gerontol A Biol Sci Med Sci. 2007;62(6):598-608.
15. Migneco G, Tripi S, Navetta A, La Ferla A, Vaccaro F. [Serum zinc concentration and antibody response to hepatitis B vaccine in hemodialysis patients]. Minerva Med. 1990;81(1-2):19-21.
16. Kouw PM, Konings CH, de Vries PM, van der Meulen J, Oe PL. Effects of zinc supplementation on zinc status and immunity in haemodialysis patients. J Trace Elem Electrolytes Health Dis. 1991;5(2):115-9.